Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

investigator Michelle O’Donoghue, MD, MPH, a senior investigator of the TIMI Study Group in the Division of Cardiovascular Medicine. Image courtesy of Michelle O'Donoghue/Brigham and Women's Hospital

News | Cardiovascular Clinical Studies

FOURIER-OLE Trial Finds that Long-term Use of Evolocumab Further Reduced Cardiovascular Events

September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...

September 08, 2022

Top 10 content for the month of August 2022

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: A Look at the Hot Topics from August

Here is a rundown of what you and your colleagues found to be most interesting in the fields of diagnostic and ...

September 07, 2022

Prespecified meta-analysis of DELIVER and EMPEROR-Preserved presented in a Hot Line Session at ESC Congress 2022

News | Pharmaceuticals

Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure

September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empag ...

September 06, 2022

Stopping statin treatment early could substantially reduce lifetime protection against heart disease since a large share of the benefit occurs later in life

News | Pharmaceuticals

Study Highlights Lifelong Benefits of Statin Therapy

September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...

September 06, 2022

Smokers have weaker hearts than non-smokers, according to research

News | Stroke

Smoking is Even More Damaging to the Heart Than Previously Thought

September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...

September 06, 2022

Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.

News | Stroke

Air Pollution is Associated with Heart Attacks in Non-Smokers

September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...

September 06, 2022

DANCAVAS trial presented in a Hot Line Session at ESC Congress 2022

News | Cardiac Imaging

Cardiovascular Screening May Reduce Risk of Death and Cardiovascular Disease

September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including car ...

September 02, 2022

DANFLU-1 trial presented in a Hot Line Session at ESC Congress 2022

News | Cardiac Imaging

Innovative Randomized Trial Hints at Mortality Benefits with High-Dose Influenza Vaccines

September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...

September 02, 2022

News | Artificial Intelligence

Artificial Intelligence Assessment of Heart Function is Superior to Sonographer Assessment

September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by a ...

September 02, 2022

REVIVED-BCIS2 trial presented in a Hot Line Session today at ESC Congress 2022

News | Heart Failure

Coronary Stenting Does Not Benefit Patients with Severe Left Ventricular Dysfunction

September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospit ...

September 02, 2022

Healthcare providers should promote prevention of atrial fibriliation, an abnormal heart rhythm disturbance, and early interventions among both female and male patients, say Cedars-Sinai investigators. Photo by Getty Images.

News | Atrial Fibrillation

Gender Differences and AFib: New Study Flips Conventional Wisdom

August 31, 2022 — Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than ...

August 31, 2022

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success

News | Heart Failure

FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial

August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...

August 29, 2022

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

August 29, 2022

A study from the Smidt Heart Institute and Cedars-Sinai's Division of Artificial Intelligence in Medicine shows that AI was more accurate in diagnosing cardiac function than sonographers. Illustration by Getty.

News | Artificial Intelligence

Late-Breaking Heart Research: AI More Accurate Than Technicians

August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...

August 29, 2022

COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, according to research presented at ESC Congress 2022.

News | Coronavirus (COVID-19)

COVID mRNA Vaccines are Safe in Patients with Heart Failure

August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...

August 26, 2022